We have to remember that what we observe is not nature in itself but nature exposed to our method of questioning.
The task of putting volume 40 of the American Journal of Sports Medicine to bed has put me in a philosophical mood, prompting reflection upon the trends that have swept through the world of orthopaedic sports medicine during the journal's lifetime. One example is the assessment of the torn anterior cruciate ligament (ACL), which has evolved dramatically over the past 4 decades. These refinements have been overwhelmingly positive, although occasionally a single outcome measure has become so fashionable that the importance of other metrics has been marginalized. In each case, however, the pendulum has ultimately swung back towards a more balanced view.
Last month, I focused on the importance of documenting athletes' capacity to return to play at their previous level following treatment for an ACL injury. Playing ability is a valuable metric because it is important to so many of our patients. Nevertheless, we know that the power of sheer determination can often enable an athlete with compromised knee function to resume competition, although the return may be quite transient and the skill level substantially reduced. Orthopaedic surgeons have recognized this for a long time and have sought other ways to assess an athlete's function and prognosis after ACL injury.
When AJSM was young and frisky, a variety of new outcome scores began to appear. Keeping score is an inherent part of most sports, so assigning a numerical value to surgical outcomes made intuitive sense and potentially allowed comparison of results among different treatments and different investigators. Some authors divided their results into a small number of categories, 19, 42 some asked the patients to assign a percentage rating to their recovery, 9, 11 while still others developed a much more elaborate scoring system. 2 In 1977, John Marshall introduced the Hospital for Special Surgery (HSS) knee score, which reflected both a patient's symptoms and the surgeon's physical examination. 31 Marshall constructed the score based upon his extensive personal experience caring for young athletes. This was a pioneering achievement, although its mingling of subjective and objective criteria may have impeded its reproducibility from one examiner to another. Nevertheless, this system achieved currency outside of the originating institution and is still sometimes reported today.
In 1982, Lysholm and Gillquist published a scoring scale designed specifically for knee ligament injuries. 29 Later, it was slightly modified 40 so that it could be completed entirely from a patient's responses to a series of questions. Although the concept of psychometric validation of an outcome score was not current among orthopaedic surgeons at the time, the authors did demonstrate that the score had test-retest reproducibility, correlated with patients' opinions of their knees, and reflected the assessment of laxity from the physical examination. Subsequent studies have validated this measure more formally. 4 The Lysholm score has enjoyed considerable popularity: To date, the original publication has been cited almost 2000 times. Because a patient's symptoms might vary with the demands placed upon the injured joint, Tegner and Lysholm soon introduced an activity rating scale 40 and performance testing 41 to complement the original subjective assessment. Performance tests have been found useful not just for reporting results but also for gauging an athlete's readiness to return to play. 28 As much laboratory research during the '70s and '80s was directed at defining the precise contribution of each structure to knee stability and the ability of reconstructive techniques to reproduce normal biomechanical function, 5, 12, 17, 22, 30, 32 it was logical to search for ways to quantitate pathological laxity after injury. There was concern that simply documenting return to play or even tallying a patient's subjective complaints could overlook subtler but nevertheless important residual abnormalities. The KT-1000 arthrometer, formally introduced in 1985, 8 quickly acquired widespread popularity and led to the creation of several alternative devices. The newfound ability to measure anterior knee laxity focused so much attention on this metric that, for a while, the sine qua non of a successful operation seemed to be a KT-1000 arthrometer reading equal to the uninjured knee.
The formation of the International Knee Documentation Committee (IKDC) produced a comprehensive evaluation system that reflected the input of not just one or two experts but a large international panel. 16 One of the great virtues of this system is that a poor outcome in one category is carried forward to the overall score, so that a substantial or clinically important deficit is not masked by good results in other aspects of the evaluation. Unfortunately, dependence on the details of the physical examination has made it difficult to document the reproducibility of the IKDC objective assessment. The subsequently developed IKDC subjective evaluation form, 20 although designed to complement the objective tool, has eclipsed it to some extent. The popularity of this and other subjective scales 3, 14, 33, 37 has stemmed from their successful validation for a number of conditions as well as a renewed emphasis on documenting the success of treatment from the patient's viewpoint. Just as ACL research had gone
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In recent years, it has been recognized that patients who rate highly on subjective outcome scores may still have important deficits and may progress to delayed joint degeneration. Evolving technology has provided the means of documenting subtler abnormalities that are beyond the limitations of more traditional metrics. Residual abnormal rotation has been measured with electromagnetic tracking devices 18 and magnetic resonance imaging (MRI). 21, 27 Optoelectronic and stereoradiographic gait analysis have been utilized to examine 3-dimensional kinematic behavior of the knee during functional activities such as walking, 13 descending stairs, and pivoting 6 or running. 39 Further refinements in MRI have led to creative uses of this technology in the investigation of ACL injuries. MRI has been used to document the differential survival of the individual components of double-bundle reconstructions, 38 compare the maturation of autografts and allografts, 24 and, with added contrast, evaluate the graft revascularization process. 35 Late development of osteoarthritis following ACL injury has long been a concern, although it is still not clear how much of this risk is contingent upon damage that occurs at the time of the initial injury and how much is secondary to damage from subsequent instability. 7, 25 Enhanced MRI techniques, including dGEMRIC, T1 rho, and T2 mapping, promise to provide a noninvasive method of tracking the health of the articular cartilage following ACL injury. 1, 10, 15, 26, 34, 36 This technology may allow us to determine whether treatment innovations are likely to have a positive effect on the risk of arthritic degeneration after ACL injury without having to wait decades for clinical findings to develop.
In 2002, Kocher and colleagues 23 published a study of the factors associated with patient satisfaction after ACL reconstruction. These elements were numerous and included objective variables such as lost motion, abnormal laxity, effusion, and tenderness; symptoms such as pain, swelling, locking, and instability episodes; and functional deficits such as difficulty with daily activities, work restrictions, and reduced level of sports participation. Because so many features contribute to a patient's satisfaction, the concurrent use of multiple outcome measures can provide a more nuanced and complete assessment of treatment results.
Contemplating the diverse means available to evaluate ACL injuries reminded me of the Indian fable of the blind men and the elephant. Because every blind man touches a different part of the elephant, they arrive at radically different impressions of the nature of the beast. Each interpretation is correct, yet incomplete; combining them all produces a much more comprehensive portrait. Evaluating an ACL injury is at least as complex as describing an elephant. If we limit our evaluation to only one facet, we run the risk of concluding that a torn ACL is rather like a fan, a rope, or a tree.
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